Alzheimer Disease
The Alzheimer's disease market in psychiatry is also witnessing significant growth, driven by the aging population and the increasing prevalence of the disease. According to a report by Mordor Intelligence, the global Alzheimer's disease market is expected to grow at a compound annual growth rate of 7.8% from 2021 to 2026, reaching a market size of 8.6 billion USD by the end of the forecast period. The market is driven by the availability of new drug therapies, increasing investment in research and development, and rising awareness of the disease. Key players in the Alzheimer's disease market include pharmaceutical companies, healthcare providers, and research organizations.